Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Spero Therapeutics Inc | SPRO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.34 | -3.1% | 10.64 | 11.23 | 10.53 | 10.93 | 10.98 | 14:36:56 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 10.44 | 10.94 | 0.50 | 4.57% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 703 | 53,207 | $ 10.81 | $ 575,336 | 46,501 | 5.52 - 14.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:17:54 | 71 | $ 10.89 | USD |
Spero Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 198.50M | 18.66M | $ -41.66M | -2.62 | - | 18.56M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Spero Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.14 | 11.37 | 10.12 | 10.8025 | 47k | 0.5 | 4.93% |
| 1 Month | 11.99 | 12.55 | 10.1 | 11.0265 | 44k | -1.35 | -11.26% |
| 3 Months | 10.36 | 12.65 | 8.855 | 10.7147 | 38k | 0.28 | 2.70% |
| 6 Months | 12.3 | 14.38 | 8.855 | 11.3202 | 49k | -1.66 | -13.50% |
| 1 Year | 9.33 | 14.48 | 5.52 | 10.4204 | 65k | 1.31 | 14.04% |
| 3 Years | 13.25 | 19 | 5.52 | 11.2644 | 77k | -2.61 | -19.70% |
| 5 Years | 13.25 | 19 | 5.52 | 11.2644 | 77k | -2.61 | -19.70% |
Spero Therapeutics Description
| Spero Therapeutics Inc is a US-based clinical-stage biopharmaceutical company. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections. The company's product candidate, SPR994, is designed as a broad-spectrum oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It has developed platform technology known as Potentiator Platform to develop drugs to expand the spectrum and potency of existing antibiotics, including formerly inactive antibiotics, against Gram-negative bacteria. In addition, the company is developing SPR720, an oral antibiotic designed for the treatment of pulmonary non-tuberculous mycobacterial infections. The pipeline products include SPR741, SPR206, and SPR720. |
